TARS Annual ROE
-69.71%
-35.18%-101.88%
31 December 2023
Summary:
As of January 23, 2025, TARS annual return on equity is -69.71%, with the most recent change of -35.18% (-101.88%) on December 31, 2023. During the last 3 years, it has fallen by -53.56% (-331.64%). TARS annual ROE is now -171.56% below its all-time high of 97.42%, reached on December 31, 2018.TARS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARS Quarterly ROE
-57.14%
+11.96%+17.31%
30 September 2024
Summary:
As of January 23, 2025, TARS quarterly return on equity is -57.14%, with the most recent change of +11.96% (+17.31%) on September 30, 2024. Over the past year, it has increased by +16.34% (+22.24%). TARS quarterly ROE is now -184.73% below its all-time high of 67.44%, reached on March 31, 2020.TARS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARS ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -101.9% | +22.2% |
| 3 y3 years | -331.6% | +22.2% |
| 5 y5 years | -171.6% | +22.2% |
TARS ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -738.9% | at low | -633.5% | +22.4% |
| 5 y | 5-year | -189.6% | at low | -184.7% | +67.6% |
| alltime | all time | -171.6% | at low | -184.7% | +67.6% |
Tarsus Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -57.14%(-17.3%) |
| June 2024 | - | -69.10%(-6.1%) |
| Mar 2024 | - | -73.59%(+0.1%) |
| Dec 2023 | -69.71%(+101.9%) | -73.48%(+27.1%) |
| Sept 2023 | - | -57.82%(+19.3%) |
| June 2023 | - | -48.47%(+39.6%) |
| Mar 2023 | - | -34.73%(+4.4%) |
| Dec 2022 | -34.53% | -33.28%(-3.4%) |
| Sept 2022 | - | -34.46%(+10.8%) |
| June 2022 | - | -31.09%(+21.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -25.52%(+227.6%) |
| Dec 2021 | -8.31%(-48.5%) | -7.79%(+34.3%) |
| Sept 2021 | - | -5.80%(+55.5%) |
| June 2021 | - | -3.73%(-75.3%) |
| Mar 2021 | - | -15.09%(-62.4%) |
| Dec 2020 | -16.15%(-120.8%) | -40.11%(-77.2%) |
| Sept 2020 | - | -176.19%(+459.5%) |
| June 2020 | - | -31.49%(-146.7%) |
| Mar 2020 | - | 67.44%(+93.5%) |
| Dec 2019 | 77.77%(-20.2%) | 34.85% |
| Dec 2018 | 97.42% | - |
FAQ
- What is Tarsus Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual ROE year-on-year change?
- What is Tarsus Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly ROE year-on-year change?
What is Tarsus Pharmaceuticals annual return on equity?
The current annual ROE of TARS is -69.71%
What is the all time high annual ROE for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual return on equity is 97.42%
What is Tarsus Pharmaceuticals annual ROE year-on-year change?
Over the past year, TARS annual return on equity has changed by -35.18% (-101.88%)
What is Tarsus Pharmaceuticals quarterly return on equity?
The current quarterly ROE of TARS is -57.14%
What is the all time high quarterly ROE for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly return on equity is 67.44%
What is Tarsus Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, TARS quarterly return on equity has changed by +16.34% (+22.24%)